Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
It is a once-weekly injectable medication that is given as a minimal dose to start and gradually increased until a therapeutic dose is reached
After 5 um cross-sections were prepared according to procedure, the intensity and distribution of the pathological spinal cord changes were evaluated semiquantitatively
Once-weekly subcutaneous semaglutide is a GLP-1 RA for the treatment of T2DM with proven superior and sustained glycaemic control and weight loss versus all comparators evaluated in the SUSTAIN phase 3 clinical trial programme [15, 16]
The notable exception to this is saxagliptin
US$ 20.94
US$ 23.95
US$ 24.48
